Terms ending in 2032
Every in-force patent on Irm LLC's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,181,235 | Substituted Pyridines for Modulating the WNT Signaling Pathway In force · High confidence | Novartis AG | In force | High confidence | |
| US 8,703,787 | Methods of Using Alk Inhibitors In force · High confidence | Novartis AG | In force | High confidence | |
| US 10,493,080 | Directed Differentiation of Oligodendrocyte Precursor Cells to a Myelinating Cell Fate In force · High confidence | Novartis AG | In force | High confidence | |
| US 10,660,899 | Directed Differentiation of Oligodendrocyte Precursor Cells to a Myelinating Cell Fate In force · High confidence | Novartis AG | In force | High confidence | |
| US 11,246,873 | Directed Differentiation of Oligodendrocyte Precursor Cells to a Myelinating Cell Fate In force · High confidence | Novartis AG | In force | High confidence | |
| US 9,150,568 | Compositions and Methods for Modulating FXR In force · High confidence | Irm LLC | In force | High confidence | |
| US 9,102,671 | Compounds and Compositions as TRK Inhibitors In force · High confidence | Irm LLC | In force | High confidence | |
| US 8,927,281 | Method for Expanding Hematopoietic Stem Cells In force · High confidence | Novartis AG | In force | High confidence | |
| US 9,045,470 | Compounds and Compositions as TLR Activity Modulators In force · High confidence | Novartis AG | In force | High confidence | |
| US 8,569,283 | Compounds and Compositions as C-Kit Kinase Inhibitors In force · High confidence | Novartis AG | In force | High confidence | |
| 3 more term ends in 2032 · Pro | |||||
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
4 of these are in force and held by Irm LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.